Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.
Shattock, AJ; JOHNSON, HC; Sim, SY; Carter, A; Lambach, P; Hutubessy, RC W; Thompson, KM; Badizadegan, K; Lambert, B; Ferrari, MJ; JIT, M; FU, H; Silal, SP; Hounsell, RA; WHITE, RG; Mosser, JF; Gaythorpe, KA M; Trotter, CL; Lindstrand, A; O'Brien, KL; Bar-Zeev, N;
2024
Lancet (London, England), (2024).403 10441 10.1016/S0140-6736(24)00850-X.
Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report.
CLARK, RA; Young, C; Palmer, S; Auma, E; Malhotra, S; Limaye, R; Giersing, B; Schrager, L; Voss, G; Tiemersma, E; Frick, M; Edoka, I; Dagnew, AF; Nkhoma, T; Pelzer, PT; WHITE, RG;
2024
Frontiers in Tuberculosis, (2024).2, 10.3389/ftubr.2024.1384036.
A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation.
Jones, K; CHISNALL, G; Crocker-Buque, T; Elliman, D; Horwood, J; MOUNIER-JACK, S; Campbell, CN; Saliba, V; CHANTLER, T;
2024
BMC Public Health, (2024).24 1 10.1186/s12889-024-18586-8.
The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.
WHITE, RG; Menzies, NA; Portnoy, A; CLARK, RA; Toscano, CM; Weller, C; Tufet Bayona, M; Silal, SP; Karron, RA; Lee, J-S; Excler, J-L; Lauer, JA; Giersing, B; Lambach, P; Hutubessy, R; JIT, M;
2024
Vaccines, (2024).12 4 10.3390/vaccines12040435.
Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis.
AUZENBERGS, M; Maure, C; KANG, H; CLARK, A; BRADY, O; Sahastrabuddhe, S; ABBAS, K;
2024
PLoS neglected tropical diseases, (2024).18 4 10.1371/journal.pntd.0012075.
Estimating the Potential Public Health Value of BCG Revaccination.
CLARK, RA; Sumner, T; Weerasuriya, CK; Bakker, R; Scriba, TJ; WHITE, RG;
2024
The Journal of infectious diseases, (2024).230 1 10.1093/infdis/jiae089.
Towards improving the quality and usefulness of GBD tuberculosis estimates.
WHITE, RG; Rao, JP;
2024
The Lancet. Infectious diseases, (2024).24 7 10.1016/s1473-3099(24)00079-3.
Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP.
Andrews, C; PRESTIGE, E; PARKER, EP K; Walker, V; Palmer, T; Schaffer, A; Green, AC A; Curtis, H; Walker, A; Smith, R; Wood, C; Bates, C; Mehrkar, A; MacKenna, B; Bacon, SC J; GOLDACRE, B; Hernán, M; Sterne, JA C; The OpenSAFELY collaborative,; Hulme, W;
2024
medRxiv (2024). 10.1101/2024.03.15.24304277.
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner, A-M; Li, X; Echeverria-Londono, S; Roth, J; ABBAS, K; AUZENBERGS, M; De Villiers, MJ; Ferrari, MJ; Fraser, K; FU, H; Hallett, T; Hinsley, W; JIT, M; Karachaliou, A; Moore, SM; Nayagam, S; Papadopoulos, T; Perkins, TA; Portnoy, A; Minh, QT; VYNNYCKY, E; Winter, AK; Burrows, H; CHEN, C; Clapham, HE; ... Gaythorpe, KA M.
2024
The Lancet Global health, (2024).12 4 10.1016/S2214-109X(23)00603-4.
Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.
ABBAS, K; Yoo, KJ; PREM, K; JIT, M;
2024
eClinicalMedicine, (2024).70, 10.1016/j.eclinm.2024.102524.